← Sharmila Dorbala

Papers by Sharmila Dorbala

Page 2 · newest first

51. Expanding indications for non-biopsy diagnosis of transthyretin amyloid cardiomyopathyEuropean Heart Journal · 2023
52. Age Dependency of Cardiovascular Outcomes With the Amyloidogenic pV142I Transthyretin Variant Among Black Individuals in the USJAMA Cardiology · 2023
53. Time and event-specific deep learning for personalized risk assessment after cardiac perfusion imagingnpj Digital Medicine · 2023
54. Unsupervised learning to characterize patients with known coronary artery disease undergoing myocardial perfusion imagingEuropean Journal of Nuclear Medicine and Molecular Imaging · 2023
55. World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)Global Heart · 2023
56. Coronary Flow Reserve, Inflammation, and Myocardial StrainJACC Basic to Translational Science · 2022
57. 99mTc Bone-Avid Tracer Cardiac Scintigraphy: Role in Noninvasive Diagnosis of Transthyretin Cardiac AmyloidosisRadiology · 2022
58. The flutemetamol analogue cyano-flutemetamol detects myocardial AL and ATTR amyloid deposits: a post-mortem histofluorescence analysisAmyloid · 2022
59. Optimal Echocardiographic Parameters to Improve the Diagnostic Yield of Tc-99m-Bone Avid Tracer Cardiac Scintigraphy for Transthyretin Cardiac AmyloidosisCirculation Cardiovascular Imaging · 2022
60. Modeling the Cost and Health Impacts of Diagnostic Strategies in Patients with Suspected Transthyretin Cardiac AmyloidosisJournal of the American Heart Association · 2022
61. Machine learning to predict abnormal myocardial perfusion from pre-test featuresJournal of Nuclear Cardiology · 2022
62. Differences in Prognostic Value of Myocardial Perfusion Single-Photon Emission Computed Tomography Using High-Efficiency Solid-State Detector Between Men and Women in a Large International Multicenter StudyCirculation Cardiovascular Imaging · 2022
63. Accuracy and Reproducibility of Myocardial Blood Flow Quantification by Single Photon Emission Computed Tomography Imaging in Patients With Known or Suspected Coronary Artery DiseaseCirculation Cardiovascular Imaging · 2022
64. Explainable Deep Learning Improves Physician Interpretation of Myocardial Perfusion ImagingJournal of Nuclear Medicine · 2022
65. Effect of tafamidis on global longitudinal strain and myocardial work in transthyretin cardiac amyloidosisEuropean Heart Journal - Cardiovascular Imaging · 2022
66. Women leaders: transforming the culture in cardiologyOpen Heart · 2022
67. Progress in Cardiac Imaging Uncovers the Epidemiology of Wild-Type Transthyretin Amyloid CardiomyopathyJACC CardioOncology · 2021
68. Concomitant Transthyretin Amyloidosis and Severe Aortic Stenosis in Elderly Indian PopulationJACC CardioOncology · 2021
69. Association of Myocardial Blood Flow Reserve With Adverse Left Ventricular Remodeling in Patients With Aortic StenosisJAMA Cardiology · 2021
70. Impact of COVID-19 Pandemic on Cardiovascular Testing in AsiaJACC Asia · 2021
71. Reduction of cardiac imaging tests during the COVID-19 pandemic: The case of Italy. Findings from the IAEA Non-invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)International Journal of Cardiology · 2021
72. Low coronary flow relative to myocardial mass predicts heart failure in symptomatic hypertensive patients with no obstructive coronary artery diseaseEuropean Heart Journal · 2021
73. Impact of COVID-19 on the imaging diagnosis of cardiac disease in EuropeOpen Heart · 2021
74. Clinical Deployment of Explainable Artificial Intelligence of SPECT for Diagnosis of Coronary Artery DiseaseJACC. Cardiovascular imaging · 2021
75. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 1 of 2—Evidence Base and Standardized Methods of ImagingCirculation Cardiovascular Imaging · 2021
76. Prognostic Value of Phase Analysis for Predicting Adverse Cardiac Events Beyond Conventional Single-Photon Emission Computed Tomography Variables: Results From the REFINE SPECT RegistryCirculation Cardiovascular Imaging · 2021
77. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2—Diagnostic Criteria and Appropriate UtilizationCirculation Cardiovascular Imaging · 2021
78. Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the WorldJACC. Cardiovascular imaging · 2021
79. Coronary Microvascular Dysfunction in Systemic Lupus ErythematosusJournal of the American Heart Association · 2021
80. Left atrial structure and function of the amyloidogenic V122I transthyretin variant in elderly African AmericansEuropean Journal of Heart Failure · 2021
81. Expert consensus on the monitoring of transthyretin amyloid cardiomyopathyEuropean Journal of Heart Failure · 2021
82. Quantitation of Poststress Change in Ventricular Morphology Improves Risk StratificationJournal of Nuclear Medicine · 2021
83. Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitionerBMC Family Practice · 2020
84. Absolute Quantitation of Cardiac 99mTc-Pyrophosphate Using Cadmium-Zinc-Telluride–Based SPECT/CTJournal of Nuclear Medicine · 2020
85. Guidance and Best Practices for Nuclear Cardiology Laboratories During the COVID-19 PandemicCirculation Cardiovascular Imaging · 2020
86. Appropriate Use Criteria for PET Myocardial Perfusion ImagingJournal of Nuclear Medicine · 2020
87. Guidance and best practices for nuclear cardiology laboratories during the coronavirus disease 2019 (COVID-19) pandemic: An Information Statement from ASNC and SNMMIJournal of Nuclear Medicine · 2020
88. Prognostically safe stress-only single-photon emission computed tomography myocardial perfusion imaging guided by machine learning: report from REFINE SPECTEuropean Heart Journal - Cardiovascular Imaging · 2020
89. Hypertensive coronary microvascular dysfunction: a subclinical marker of end organ damage and heart failureEuropean Heart Journal · 2020
90. Geographic variation in public interest about amyloidosis in the United States and English speaking countriesAmyloid · 2020
91. Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney ImpairmentCirculation · 2019
92. Myocardial Ischemic Burden and Differences in Prognosis Among Patients With and Without Diabetes: Results From the Multicenter International REFINE SPECT RegistryDiabetes Care · 2019
93. Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac AmyloidosisCirculation Heart Failure · 2019
94. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2—evidence base and standardized methods of imagingJournal of Nuclear Cardiology · 2019
95. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 2 of 2—Diagnostic criteria and appropriate utilizationJournal of Nuclear Cardiology · 2019
96. Machine learning predicts per-vessel early coronary revascularization after fast myocardial perfusion SPECT: results from multicentre REFINE SPECT registryEuropean Heart Journal - Cardiovascular Imaging · 2019
97. Transient ischaemic dilation and post-stress wall motion abnormality increase risk in patients with less than moderate ischaemia: analysis of the REFINE SPECT registryEuropean Heart Journal - Cardiovascular Imaging · 2019
98. Diagnostic Accuracy of Advanced Imaging in Cardiac SarcoidosisCirculation Cardiovascular Imaging · 2019
99. Epidemiology of Cardiac Amyloidosis–Associated Heart Failure Hospitalizations Among Fee-for-Service Medicare Beneficiaries in the United StatesCirculation Heart Failure · 2019
100. Stress Myocardial Perfusion PET Provides Incremental Risk Prediction in Patients with and Patients without DiabetesRadiology Cardiothoracic Imaging · 2019